DNA and modified vaccinia Ankara prime-boost vaccination generates strong CD8 ⁺ T cell responses against minor histocompatibility antigen HA-1.

Autor: Eldershaw SA; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK., Pearce H; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK., Inman CF; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK., Piper KP; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK., Abbotts B; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK., Stephens C; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK., Nicol S; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK., Croft W; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK., Powell R; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK., Begum J; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK., Taylor G; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK., Nunnick J; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Walsh D; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Sirovica M; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Saddique S; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Nagra S; Department of Haematology, Birmingham Health Partners, Queen Elizabeth Hospital, Birmingham, UK., Ferguson P; Department of Haematology, Birmingham Health Partners, Queen Elizabeth Hospital, Birmingham, UK., Moss P; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK.; Department of Haematology, Birmingham Health Partners, Queen Elizabeth Hospital, Birmingham, UK., Malladi R; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK.; Department of Haematology, Birmingham Health Partners, Queen Elizabeth Hospital, Birmingham, UK.

Publikováno v: British journal of haematology [Br J Haematol] 2021 Nov; Vol. 195 (3), pp. 433-446. Date of Electronic Publication: 2021 May 28.

Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease.

Autor: Kinsella FAM; School of Cancer Sciences, University of Birmingham, Birmingham, UK; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK., Inman CF; School of Cancer Sciences, University of Birmingham, Birmingham, UK., Gudger A; Heartlands Hospital, Heart of England NHS Foundation trust, Birmingham, UK., Chan YT; School of Cancer Sciences, University of Birmingham, Birmingham, UK., Murray DJ; School of Cancer Sciences, University of Birmingham, Birmingham, UK., Zuo J; School of Cancer Sciences, University of Birmingham, Birmingham, UK., McIlroy G; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK., Nagra S; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK., Nunnick J; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK., Holder K; Heartlands Hospital, Heart of England NHS Foundation trust, Birmingham, UK., Wall K; West Midlands Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK., Griffiths M; School of Cancer Sciences, University of Birmingham, Birmingham, UK; West Midlands Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK., Craddock C; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK., Nikolousis E; Heartlands Hospital, Heart of England NHS Foundation trust, Birmingham, UK., Moss P; School of Cancer Sciences, University of Birmingham, Birmingham, UK; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK. Electronic address: p.moss@bham.ac.uk., Malladi R; School of Cancer Sciences, University of Birmingham, Birmingham, UK; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK.

Publikováno v: Leukemia research [Leuk Res] 2019 Aug; Vol. 83, pp. 106173. Date of Electronic Publication: 2019 Jun 18.

Unique features and clinical importance of acute alloreactive immune responses.

Autor: Inman CF; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, and., Eldershaw SA; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, and., Croudace JE; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, and., Davies NJ; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, and., Sharma-Oates A; Centre for Computational Biology, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Rai T; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, and., Pearce H; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, and., Sirovica M; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, and., Chan YLT; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, and., Verma K; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, and., Zuo J; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, and., Nagra S; Birmingham Health Partners, Department of Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom., Kinsella F; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, and., Nunnick J; Birmingham Health Partners, Department of Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom., Amel-Kashipaz R; Birmingham Health Partners, Department of Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom., Craddock C; Birmingham Health Partners, Department of Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom., Malladi R; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, and.; Birmingham Health Partners, Department of Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom., Moss P; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, and.; Birmingham Health Partners, Department of Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom.

Publikováno v: JCI insight [JCI Insight] 2018 May 17; Vol. 3 (10). Date of Electronic Publication: 2018 May 17 (Print Publication: 2018).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Direct experimental evidence that early-life farm environment influences regulation of immune responses.

Autor: Lewis, Marie C.¹, Inman, Charlotte F.¹, Patel, Dilip¹, Schmidt, Bettina², Mulder, Imke², Miller, Bevis¹, Gill, Bhupinder P.³, Pluske, John⁴, Kelly, Denise², Stokes, Christopher R.¹, Bailey, Michael¹

Publikováno v: Pediatric Allergy & Immunology. May2012, Vol. 23 Issue 3, p265-269. 5p. 2 Graphs.